sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
ASEAN Pharmaceutical Manufacturing Market 2017-2027 by Formulation and Country: Trend Forecast and Growth Opportunity

ASEAN Pharmaceutical Manufacturing Market 2017-2027 by Formulation and Country: Trend...

Home / Categories / Healthcare
ASEAN Pharmaceutical Manufacturing Market 2017-2027 by Formulation and Country: Trend Forecast and Growth Opportunity
ASEAN Pharmaceutical Manufacturing Market 2017-2027...
Report Code
RO1/105/1114

Publish Date
30/Mar/2021

Pages
66
PRICE
$ 2000/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 3000/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 4000/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
ASEAN pharmaceutical manufacturing industry will grow by 12.8% annually with a total addressable market cap of $148.3 billion over 2021-2027 driven by increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic.
Highlighted with 25 tables and 39 figures, this 66-page report "ASEAN Pharmaceutical Manufacturing Market 2017-2027 by Formulation and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire ASEAN pharmaceutical manufacturing industry and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Industry Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Industry Opportunities
- Porter's Fiver Forces
The trend and outlook of ASEAN industry is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify ASEAN pharmaceutical manufacturing industry in every aspect of the classification from perspectives of Formulation and Country.

Based on Formulation, the ASEAN industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
- Tablets
- Capsules
- Injectable
- Sprays
- Suspensions
- Powders
- Other Formulations

Geographically, the following national/local markets are fully investigated:
- Indonesia
- Thailand
- Philippines
- Vietnam
- Singapore
- Malaysia
- Myanmar
- Cambodia
- Laos
- Brunei
For each key country, detailed analysis and data for annual production value are available for 2017-2027. The breakdown of key national industry by Formulation and Manufacturer is also included.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com